Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2015 (2015), Article ID 192736, 8 pages
Research Article

Anti-Thyroid Peroxidase Antibody in Vitiligo: A Prevalence Study

1Department of Dermatology, Venereology and Leprosy, Jawaharlal Nehru Medical College and Dr. Prabhakar Kore KLES Hospital, Belgaum, Karnataka 590010, India
2The INCLEN Trust International, New Delhi 110020, India

Received 27 September 2014; Revised 20 December 2014; Accepted 21 December 2014

Academic Editor: Fausto Bogazzi

Copyright © 2015 R. Dash et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Aim. The aim of the study was to study the relation of vitiligo with demographic data like age, sex, and duration and determine the prevalence of thyroid autoimmunity in vitiligo patients. Materials and Methods. This study was a cross sectional study consisting of 100 patients clinically diagnosed (old and new) as having vitiligo irrespective of age or sex. Patients with known thyroid disease on supplementation therapy, or who had undergone thyroid surgery, those on antithyroid medication, patients with other causes of leukoderma, and cases who do not provide informed consent were excluded from the study. Serum TSH and anti-TPO antibodies were measured in all the patients. Results. The prevalence of anti-TPO antibody positivity was found to be 28%. Conclusion. According to our study, none of our vitiligo patients had symptoms or signs of thyroid disease at the time of presentation but, on biochemical evaluation, anti-TPO antibodies were found in a considerable number of patients. Hence, we recommend screening of these patients with thyroid antibodies.